HEADER UNKNOWN FUNCTION 03-APR-19 6R99 TITLE CRYSTAL STRUCTURE OF HUMAN CLN PROTEIN 5 (CEROID LIPOFUSCINOSIS TITLE 2 NEURONAL PROTEIN 5) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CEROID-LIPOFUSCINOSIS NEURONAL PROTEIN 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CEROID-LIPOFUSCINOSIS,NEURONAL 5,ISOFORM CRA_A; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: PROTEIN CONTAINS SELENOMETHIONINE AND IS GLYCOSYLATED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLN5, HCG_28176; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCDNA3 KEYWDS NEURONAL CEROID LIPOFISCINOSIS, CLN5, CIRCULARLY-PERMUTED PAPAIN-LIKE KEYWDS 2 FOLD, GLYCOPROTEIN, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR A.V.LUEBBEN,G.M.SHELDRICK REVDAT 3 28-SEP-22 6R99 1 JRNL HETSYN REVDAT 2 29-JUL-20 6R99 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 22-APR-20 6R99 0 JRNL AUTH A.V.LUEBBEN,D.BENDER,S.BECKER,L.M.CROWTHER,I.ERVEN, JRNL AUTH 2 K.HOFMANN,J.SODING,H.KLEMP,C.BELLOTTI,A.STAUBLE,T.QIU, JRNL AUTH 3 R.S.KATHAYAT,B.C.DICKINSON,J.GARTNER,G.M.SHELDRICK, JRNL AUTH 4 R.KRATZNER,R.STEINFELD JRNL TITL CLN5 REPRESENTS A NEW TYPE OF CYSTEINE-BASED S JRNL TITL 2 -DEPALMITOYLASE LINKED TO NEURODEGENERATION. JRNL REF SCI ADV V. 8 J8633 2022 JRNL REFN ESSN 2375-2548 JRNL PMID 35427157 JRNL DOI 10.1126/SCIADV.ABJ8633 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.930 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 10354 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.0521 - 4.2852 1.00 2578 141 0.2143 0.2183 REMARK 3 2 4.2852 - 3.4017 1.00 2433 141 0.2044 0.2317 REMARK 3 3 3.4017 - 2.9718 1.00 2388 135 0.2395 0.3020 REMARK 3 4 2.9718 - 2.7002 1.00 2422 116 0.2722 0.3758 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2494 REMARK 3 ANGLE : 0.727 3406 REMARK 3 CHIRALITY : 0.044 369 REMARK 3 PLANARITY : 0.005 429 REMARK 3 DIHEDRAL : 3.243 1427 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6R99 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-APR-19. REMARK 100 THE DEPOSITION ID IS D_1292101022. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19772 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 44.046 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 27.82 REMARK 200 R MERGE (I) : 0.22900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.18 REMARK 200 R MERGE FOR SHELL (I) : 1.29400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXDE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MAGNESIUM NITRATE, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 119.36667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 59.68333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 59.68333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 119.36667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 634 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ARG A 2 REMARK 465 ARG A 3 REMARK 465 ASN A 4 REMARK 465 LEU A 5 REMARK 465 ARG A 6 REMARK 465 LEU A 7 REMARK 465 GLY A 8 REMARK 465 PRO A 9 REMARK 465 SER A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 ALA A 13 REMARK 465 ASP A 14 REMARK 465 ALA A 15 REMARK 465 GLN A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 GLY A 19 REMARK 465 ALA A 20 REMARK 465 PRO A 21 REMARK 465 ARG A 22 REMARK 465 PRO A 23 REMARK 465 GLY A 24 REMARK 465 LEU A 25 REMARK 465 ALA A 26 REMARK 465 ALA A 27 REMARK 465 PRO A 28 REMARK 465 ARG A 29 REMARK 465 MSE A 30 REMARK 465 LEU A 31 REMARK 465 LEU A 32 REMARK 465 PRO A 33 REMARK 465 PRO A 34 REMARK 465 ALA A 35 REMARK 465 SER A 36 REMARK 465 GLN A 37 REMARK 465 ALA A 38 REMARK 465 SER A 39 REMARK 465 ARG A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 GLY A 43 REMARK 465 SER A 44 REMARK 465 THR A 45 REMARK 465 GLY A 46 REMARK 465 CYS A 47 REMARK 465 SER A 48 REMARK 465 LEU A 49 REMARK 465 MSE A 50 REMARK 465 ALA A 51 REMARK 465 GLN A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 ASP A 55 REMARK 465 THR A 56 REMARK 465 ALA A 57 REMARK 465 GLN A 58 REMARK 465 GLY A 59 REMARK 465 ALA A 60 REMARK 465 GLU A 61 REMARK 465 MSE A 62 REMARK 465 ARG A 63 REMARK 465 ARG A 64 REMARK 465 GLY A 65 REMARK 465 ALA A 66 REMARK 465 GLY A 67 REMARK 465 ALA A 68 REMARK 465 ALA A 69 REMARK 465 ARG A 70 REMARK 465 GLY A 71 REMARK 465 ARG A 72 REMARK 465 ALA A 73 REMARK 465 SER A 74 REMARK 465 TRP A 75 REMARK 465 CYS A 76 REMARK 465 TRP A 77 REMARK 465 ALA A 78 REMARK 465 LEU A 79 REMARK 465 ALA A 80 REMARK 465 LEU A 81 REMARK 465 LEU A 82 REMARK 465 TRP A 83 REMARK 465 LEU A 84 REMARK 465 ALA A 85 REMARK 465 VAL A 86 REMARK 465 VAL A 87 REMARK 465 PRO A 88 REMARK 465 GLY A 89 REMARK 465 TRP A 90 REMARK 465 SER A 91 REMARK 465 ARG A 92 REMARK 465 VAL A 93 REMARK 465 SER A 94 REMARK 465 GLY A 95 REMARK 465 ILE A 96 REMARK 465 PRO A 97 REMARK 465 SER A 98 REMARK 465 TRP A 151 REMARK 465 GLU A 152 REMARK 465 PHE A 153 REMARK 465 LYS A 154 REMARK 465 TYR A 155 REMARK 465 GLY A 156 REMARK 465 ASP A 157 REMARK 465 LEU A 158 REMARK 465 LEU A 159 REMARK 465 GLY A 160 REMARK 465 HIS A 347 REMARK 465 LEU A 348 REMARK 465 PRO A 349 REMARK 465 THR A 350 REMARK 465 LYS A 351 REMARK 465 GLU A 352 REMARK 465 ARG A 400 REMARK 465 ASN A 401 REMARK 465 LYS A 402 REMARK 465 THR A 403 REMARK 465 LEU A 404 REMARK 465 SER A 405 REMARK 465 GLY A 406 REMARK 465 LEU A 407 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 99 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 100 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 101 CG ND1 CD2 CE1 NE2 REMARK 470 TRP A 102 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 102 CZ3 CH2 REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 TYR A 123 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 HIS A 161 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 162 CG CD1 CD2 REMARK 470 LYS A 163 CG CD CE NZ REMARK 470 GLU A 226 CG CD OE1 OE2 REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 THR A 328 OG1 CG2 REMARK 470 PHE A 385 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 253 O HOH A 601 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 102 -72.50 -45.92 REMARK 500 GLN A 189 174.16 74.01 REMARK 500 CYS A 208 64.05 -116.99 REMARK 500 GLU A 226 -71.85 -63.19 REMARK 500 ASP A 279 -157.01 -135.25 REMARK 500 ILE A 365 -61.52 -92.36 REMARK 500 PHE A 385 -145.69 58.26 REMARK 500 PHE A 387 -79.92 63.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 635 DISTANCE = 6.34 ANGSTROMS DBREF1 6R99 A 1 407 UNP A0A024R644_HUMAN DBREF2 6R99 A A0A024R644 1 407 SEQRES 1 A 407 MSE ARG ARG ASN LEU ARG LEU GLY PRO SER SER GLY ALA SEQRES 2 A 407 ASP ALA GLN GLY GLN GLY ALA PRO ARG PRO GLY LEU ALA SEQRES 3 A 407 ALA PRO ARG MSE LEU LEU PRO PRO ALA SER GLN ALA SER SEQRES 4 A 407 ARG GLY SER GLY SER THR GLY CYS SER LEU MSE ALA GLN SEQRES 5 A 407 GLU VAL ASP THR ALA GLN GLY ALA GLU MSE ARG ARG GLY SEQRES 6 A 407 ALA GLY ALA ALA ARG GLY ARG ALA SER TRP CYS TRP ALA SEQRES 7 A 407 LEU ALA LEU LEU TRP LEU ALA VAL VAL PRO GLY TRP SER SEQRES 8 A 407 ARG VAL SER GLY ILE PRO SER ARG ARG HIS TRP PRO VAL SEQRES 9 A 407 PRO TYR LYS ARG PHE ASP PHE ARG PRO LYS PRO ASP PRO SEQRES 10 A 407 TYR CYS GLN ALA LYS TYR THR PHE CYS PRO THR GLY SER SEQRES 11 A 407 PRO ILE PRO VAL MSE GLU GLY ASP ASP ASP ILE GLU VAL SEQRES 12 A 407 PHE ARG LEU GLN ALA PRO VAL TRP GLU PHE LYS TYR GLY SEQRES 13 A 407 ASP LEU LEU GLY HIS LEU LYS ILE MSE HIS ASP ALA ILE SEQRES 14 A 407 GLY PHE ARG SER THR LEU THR GLY LYS ASN TYR THR MSE SEQRES 15 A 407 GLU TRP TYR GLU LEU PHE GLN LEU GLY ASN CYS THR PHE SEQRES 16 A 407 PRO HIS LEU ARG PRO GLU MSE ASP ALA PRO PHE TRP CYS SEQRES 17 A 407 ASN GLN GLY ALA ALA CYS PHE PHE GLU GLY ILE ASP ASP SEQRES 18 A 407 VAL HIS TRP LYS GLU ASN GLY THR LEU VAL GLN VAL ALA SEQRES 19 A 407 THR ILE SER GLY ASN MSE PHE ASN GLN MSE ALA LYS TRP SEQRES 20 A 407 VAL LYS GLN ASP ASN GLU THR GLY ILE TYR TYR GLU THR SEQRES 21 A 407 TRP ASN VAL LYS ALA SER PRO GLU LYS GLY ALA GLU THR SEQRES 22 A 407 TRP PHE ASP SER TYR ASP CYS SER LYS PHE VAL LEU ARG SEQRES 23 A 407 THR PHE ASN LYS LEU ALA GLU PHE GLY ALA GLU PHE LYS SEQRES 24 A 407 ASN ILE GLU THR ASN TYR THR ARG ILE PHE LEU TYR SER SEQRES 25 A 407 GLY GLU PRO THR TYR LEU GLY ASN GLU THR SER VAL PHE SEQRES 26 A 407 GLY PRO THR GLY ASN LYS THR LEU GLY LEU ALA ILE LYS SEQRES 27 A 407 ARG PHE TYR TYR PRO PHE LYS PRO HIS LEU PRO THR LYS SEQRES 28 A 407 GLU PHE LEU LEU SER LEU LEU GLN ILE PHE ASP ALA VAL SEQRES 29 A 407 ILE VAL HIS LYS GLN PHE TYR LEU PHE TYR ASN PHE GLU SEQRES 30 A 407 TYR TRP PHE LEU PRO MSE LYS PHE PRO PHE ILE LYS ILE SEQRES 31 A 407 THR TYR GLU GLU ILE PRO LEU PRO ILE ARG ASN LYS THR SEQRES 32 A 407 LEU SER GLY LEU MODRES 6R99 MSE A 135 MET MODIFIED RESIDUE MODRES 6R99 MSE A 165 MET MODIFIED RESIDUE MODRES 6R99 MSE A 182 MET MODIFIED RESIDUE MODRES 6R99 MSE A 202 MET MODIFIED RESIDUE MODRES 6R99 MSE A 240 MET MODIFIED RESIDUE MODRES 6R99 MSE A 244 MET MODIFIED RESIDUE MODRES 6R99 MSE A 383 MET MODIFIED RESIDUE HET MSE A 135 8 HET MSE A 165 8 HET MSE A 182 8 HET MSE A 202 8 HET MSE A 240 8 HET MSE A 244 8 HET MSE A 383 8 HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 501 14 HET NAG A 507 14 HETNAM MSE SELENOMETHIONINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 1 MSE 7(C5 H11 N O2 SE) FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 6 HOH *35(H2 O) HELIX 1 AA1 PHE A 188 PHE A 195 1 8 HELIX 2 AA2 ASP A 220 GLU A 226 1 7 HELIX 3 AA3 GLY A 238 GLY A 255 1 18 HELIX 4 AA4 ASP A 279 PHE A 294 1 16 HELIX 5 AA5 GLU A 321 PHE A 325 1 5 HELIX 6 AA6 ASN A 330 TYR A 342 1 13 HELIX 7 AA7 PRO A 343 LYS A 345 5 3 HELIX 8 AA8 LEU A 354 ILE A 365 1 12 SHEET 1 AA1 5 GLY A 211 GLU A 217 0 SHEET 2 AA1 5 ASN A 179 GLU A 186 -1 N GLU A 183 O CYS A 214 SHEET 3 AA1 5 MSE A 165 SER A 173 -1 N PHE A 171 O TYR A 180 SHEET 4 AA1 5 ASP A 140 PRO A 149 -1 N ALA A 148 O HIS A 166 SHEET 5 AA1 5 THR A 229 SER A 237 -1 O VAL A 231 N ARG A 145 SHEET 1 AA2 5 THR A 273 PHE A 275 0 SHEET 2 AA2 5 ASN A 262 LYS A 264 -1 N VAL A 263 O TRP A 274 SHEET 3 AA2 5 ASN A 304 SER A 312 1 O ILE A 308 N ASN A 262 SHEET 4 AA2 5 GLU A 377 GLU A 394 -1 O LYS A 389 N PHE A 309 SHEET 5 AA2 5 THR A 316 ASN A 320 -1 N LEU A 318 O TYR A 378 SHEET 1 AA3 5 THR A 273 PHE A 275 0 SHEET 2 AA3 5 ASN A 262 LYS A 264 -1 N VAL A 263 O TRP A 274 SHEET 3 AA3 5 ASN A 304 SER A 312 1 O ILE A 308 N ASN A 262 SHEET 4 AA3 5 GLU A 377 GLU A 394 -1 O LYS A 389 N PHE A 309 SHEET 5 AA3 5 GLN A 369 TYR A 374 -1 N PHE A 370 O LEU A 381 SSBOND 1 CYS A 119 CYS A 208 1555 1555 2.03 SSBOND 2 CYS A 126 CYS A 214 1555 1555 2.03 LINK C VAL A 134 N MSE A 135 1555 1555 1.33 LINK C MSE A 135 N GLU A 136 1555 1555 1.33 LINK C ILE A 164 N MSE A 165 1555 1555 1.33 LINK C MSE A 165 N HIS A 166 1555 1555 1.33 LINK ND2 ASN A 179 C1 NAG A 501 1555 1555 1.44 LINK C THR A 181 N MSE A 182 1555 1555 1.33 LINK C MSE A 182 N GLU A 183 1555 1555 1.33 LINK ND2 ASN A 192 C1 NAG B 1 1555 1555 1.44 LINK C GLU A 201 N MSE A 202 1555 1555 1.33 LINK C MSE A 202 N ASP A 203 1555 1555 1.34 LINK C ASN A 239 N MSE A 240 1555 1555 1.33 LINK C MSE A 240 N PHE A 241 1555 1555 1.34 LINK C GLN A 243 N MSE A 244 1555 1555 1.33 LINK C MSE A 244 N ALA A 245 1555 1555 1.34 LINK ND2 ASN A 252 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 304 C1 NAG A 507 1555 1555 1.44 LINK C PRO A 382 N MSE A 383 1555 1555 1.33 LINK C MSE A 383 N LYS A 384 1555 1555 1.33 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 CRYST1 58.420 58.420 179.050 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017117 0.009883 0.000000 0.00000 SCALE2 0.000000 0.019766 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005585 0.00000